‘I just never wanted them to feel uncomfortable’: Barriers to pharmacy-based identification and treatment of hepatitis C in Victoria, Canada

Original research
by
Selfridge, Marion et al

Release Date

2024

Geography

Canada

Language of Resource

English

Full Text Available

Yes

Open Access / OK to Reproduce

No

Peer Reviewed

Yes

Objective

This study seeks to determine whether successes in engaging people who use drugs (PWUD) in HCV therapy (such as in Scotland) with simplified, task-shifted cascade of care, can be replicated at community pharmacies in Victoria BC.

Findings/Key points

This innovative pharmacy-based approach found people with limited connection to primary health care to test and treat HCV but requires more training and support to be more widely feasible.

Design/methods

Four pharmacies who work with PWUD and provide opioid agonist therapy were trained to provide consent and perform point-of-care HCV antibody screening. They were supported by study nurse to link to HCV RNA testing when antibody positive patients were identified, with HCV treatment offered to RNA positive participants. Qualitative interviews were conducted with five pharmacy staff to explore experiences and feasibility of pharmacists in HCV care cascade.

Keywords

Barriers and enablers
Harm reduction
Wrap-around services